Skip to main navigation Skip to search Skip to main content

[Management of nausea and vomiting in cancer patients. Use of transdermal patches containing granisetron in patients affected by head and neck squamous-cell carcinoma]

Translated title of the contribution: Management of nausea and vomiting in cancer patients. Use of transdermal patches containing granisetron in patients affected by head and neck squamous-cell carcinoma

Research output: Contribution to journalArticlepeer-review

Abstract

In the management of cancer patients, supportive therapies play a crucial role. In patients with HNSCC in particular, swallowing may be difficult or completely prevented, therefore it is necessary to resort to alternative routes of administration instead of the oral one. The use of transdermal patches containing granisetron is thereby particularly indicated for the management of nausea and vomiting in these patients, ensuring a better quality of life and better compliance to the antineoplastic therapy.

Translated title of the contributionManagement of nausea and vomiting in cancer patients. Use of transdermal patches containing granisetron in patients affected by head and neck squamous-cell carcinoma
Original languageItalian
Pages (from-to)3-5
Number of pages3
JournalRecenti Progressi in Medicina
Volume109
Issue number11
DOIs
Publication statusPublished - 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Management of nausea and vomiting in cancer patients. Use of transdermal patches containing granisetron in patients affected by head and neck squamous-cell carcinoma'. Together they form a unique fingerprint.

Cite this